Rani Therapeutics Holdings Inc (RANI)
Healthcare
Biotechnology
0.80 $
+3.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Rani Therapeutics Holdings Inc (RANI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -26 | -15 | -32 | -47 | -51 | -35 | -19 | |
| 0.6 | 0.6 | 0.5 | 0.5 | 0.8 | 1.0 | 0.9 | |
| – | 0.0 | 23 | 16 | 19 | 16 | 12 | |
| -0.1 | 0.1 | -21 | 16 | – | – | – | |
| -0.2 | 1.0 | -3.4 | 0.5 | -2.1 | -0.5 | 7.0 | |
| 1.6 | 1.2 | 0.5 | 1.6 | 1.2 | 0.3 | 0.1 | |
| -1.5 | -1.2 | -0.5 | -72 | 30 | 20 | -7.0 | |
| – | – | – | 30 | – | – | – | |
| – | – | – | 0.0 | 0.0 | 0.3 | – | |
| 4.0 | 4.0 | -4.6 | 30 | 0.0 | -5.0 | -21 | |
| 0.9 | 73 | 77 | 29 | 0.2 | 14 | 40 | |
| -27 | 57 | 44 | -90 | -21 | -2.1 | 15 | |
| -28 | -16 | -33 | -48 | -52 | -36 | -19 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.